Australia's largest stock trading and investment forum Australia's #1 stock forum

IMU

4.00%

4.8¢ imugene limited

Taureanbull.Good points. Thanks.

First 18206 Last

Share
Profile

Follow
Bobbin

3,219 Posts.

91

04/09/22

20:56

Post #: 63511979
Share

Originally posted by Taureanbull: ↑

Any company with a high quality BOD woukd waste and time or money looking for a TGA approval. The TGA and the APVMA are bureaucratic swamps. And the Australian market is too small to waste time on.

IMU will get their platforms approved very quickly by the FDA. And the EU approvals will be fast also. IMU’s products are accumulating massive safety data. That’s the biggest hurdle. Efficacy will be very easy to prove up. IMU is not chasing a 5% improvement on the SOC. They are obliterating solid tumors. We can watch this live on a PET SCAN.

What we s going in IMU ‘s favour here is the massive unmet need. There is zero safe options providing effective treatments for solid tumors. That’s where the estimated US$450-$900bn PA market opportunity lies.

Fo those here suffering from frustration with the disconnect between scientific progress and shareprice progress, you can relax knowing that LC is putting in 10X more effort into raising awareness with Big Pharma and Big Biotech than she is with shareholders. And she does an amazing job of keeping shareholders updated.

When the time is right this company will reflect true value very rapidly. LC has already laid out the timeline for this . “In the next 6-12 months we will rock the world “. That’s the timeframe. We could expect some movement before then, as early buyers get set.

When the IMU/Celularity/Eureka deal becomes “front page news” , it will alert NASDAQ investors to this very disruptive technology. Seems like disruptive technologies stay flat for a very long time and then explode. That’s what Ben calls the tipping point.

Expand

Taureanbull.

Good points. Thanks.

IMU Price at posting: 24.5¢ Sentiment: Hold Disclosure: Not Held
4 Upvote

1 Great analysis

Reply

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

There are more pages in this discussion • 16,617 more messages in this thread...

First 18206 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.8¢		Change -0.002(4.00%)		Mkt cap ! $356.9M

Open	High	Low	Value	Volume
5.0¢	5.0¢	4.7¢	$2.298M	47.86M

Buyers (Bids)

No.	Vol.	Price($)
5	1925982	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	3452098	12

View Market Depth

No.	Vol.	Price($)
5	1925982	0.048
33	4297134	0.047
47	3841303	0.046
53	6064000	0.045
11	2329545	0.044

Price($)	Vol.	No.
0.049	2620667	8
0.050	2639213	14
0.051	6431004	11
0.052	2071350	7
0.053	418882	5

Last trade - 16.10pm 27/09/2024 (20 minute delay)

IMU (ASX) Chart

Taureanbull.Good points. Thanks.

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Taureanbull.Good points. Thanks.

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

The winners & losers on market if negative gearing were gone

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News